Executive Summary
Six mega contracts totaling $6.2B obligated value signal strong federal commitment to long-term projects in DOE remediation, defense R&D, health IT, biotech, and DHS facilities, with Savannah River Mission Completion capturing 40% ($2.37B) via two DOE awards. All bullish with $14B+ potential via options, providing multi-year revenue visibility through 2032 amid steady outlays in mature contracts. Investors should prioritize DOE environmental services and health/gov IT for stable cash flows, monitoring option exercises for 2x+ upside.
Tracking the trend? Catch up on the prior Mega Contracts Monitor ($100M+) digest from March 06, 2026.
Investment Signals(3)
- DOE Remediation Boom for SRMC(HIGH)▲
Two contracts totaling $2.37B obligated ($8.42B potential) to Savannah River Mission Completion underscore DOE's multi-billion push for Savannah River site liquid waste and tank closure through 2031.
- Long-Term Health IT and Biotech Stability(HIGH)▲
$2.05B across Oracle and Amgen for VA EHRM hosting to 2026 and HHS thrombocytopenia R&D to 2032, with $712M already outlayed in Amgen, affirm federal healthcare pipeline funding.
- Defense R&D Momentum for SAIC(MEDIUM)▲
$1.44B GSA award for software life cycle to 2025 highlights repeatable defense R&D demand, with $2.9B ceiling via options.
Risk Flags(3)
- Execution[HIGH RISK]▼
Zero or negative outlays in 50% of contracts (Oracle $0, SAIC -$175K, GardaWorld $0) signal potential delays despite high obligations.
- Execution[MEDIUM RISK]▼
Firm fixed price terms in 50% of awards (Oracle, Amgen, GardaWorld) expose to cost inflation over 8-10 year horizons.
- Market[MEDIUM RISK]▼
Long durations to 2031-2032 (67% of value) vulnerable to budget shifts in DOE/HHS.
Opportunities(2)
- ◆
$7.8B+ in unobligated options across all contracts, led by SRMC's $5.3B+$0.76B DOE upside.
- ◆
Recurring full/open competition wins for non-small businesses in remediation, defense, and health position incumbents for follow-ons.
Sector Themes(2)
- ◆
38% of value ($2.37B) in two SRMC awards for Savannah River waste/tank ops to 2031 highlights sustained nuclear cleanup spend.
- ◆
33% of value ($2.05B) in VA/HHS IT and biotech R&D through 2026-2032 with high outlays signals embedded healthcare modernization.
Watch List(3)
- 👁
{"entity"=>"Savannah River Mission Completion, LLC", "reason"=>"Dominates 40% of period value with $8.4B potential in DOE remediation.", "trigger"=>"Option funding >$1B or contract extensions"}
- 👁
{"entity"=>"SAIC", "reason"=>"Largest non-DOE award ($1.44B) with subaward dependencies and 2025 expiry.", "trigger"=>"Follow-on GSA defense R&D awards"}
- 👁
{"entity"=>"DOE Savannah River Budget", "reason"=>"Underpins 38% of value; shifts could cascade to SRMC.", "trigger"=>"FY2027 appropriations variance >10%"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 6 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC